NCT04221087 is a Phase 4 clinical trial of Dexamethasone Oral in Bronchiolitis, Viral, sponsored by Allison Williams.

Who is sponsoring NCT04221087?

NCT04221087 is sponsored by Allison Williams.

What drugs are being tested in NCT04221087?

Interventions in NCT04221087: Placebos, Dexamethasone Oral.

What condition does NCT04221087 study?

NCT04221087 studies Bronchiolitis, Viral.

Is NCT04221087 still recruiting?

NCT04221087 is currently terminated. Last updated 21 March 2023.

Are results published for NCT04221087?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-03-21 · How we verify

NCT04221087

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Steroid Use in Non-RSV Bronchiolitis

Terminated Phase 4 Results posted Last updated 21 March 2023

What this trial tests

Phase 4 trial testing Placebos in Bronchiolitis, Viral in 3 participants. Terminated before completion.

Timeline

3 February 2020

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Allison Williams
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	3
Start date	3 February 2020
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across United States

Drugs / interventions tested

Placebos — full drug profile →
Dexamethasone Oral — full drug profile →

Conditions studied

Bronchiolitis, Viral — all drugs for Bronchiolitis, Viral →

Sponsor

Allison Williams

Who can join

Adults 1 Day to 2, any sex, with Bronchiolitis, Viral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study is a pilot randomized control trial to determine the efficacy of dexamethasone use in hospitalized children who are less than 2 years of age with non-respiratory syncytial virus (RSV) bronchiolitis admitted to the University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh from February 1 to May 31, 2022. It is hypothesized that the use of standard airway-dose steroids (0.6mg/kg dexamethasone) will improve the clinical outcome of children hospitalized for non-RSV bronchiolitis, which will be evident by decreased length of stay.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexamethasone Oral

Trials testing the same drug.

NCT05986318 — Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease · Phase 2 · recruiting
NCT06126354 — Dexamethasone/Pancreatic Clamp P&F · Phase 1 · withdrawn
NCT06331520 — NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens · Phase 3 · completed
NCT05994183 — The Bronchiolitis in Hospitalized Infants Study · EARLY_PHASE1 · withdrawn
NCT06016465 — Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? · EARLY_PHASE1 · recruiting

Other recruiting trials for Bronchiolitis, Viral

Currently open trials in the same condition.

NCT04740294 — Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis · Phase 2, PHASE3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04221087 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Allison Williams
Last refreshed: 21 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04221087.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing